Data from the Evoke trials suggests that GLP-1 drugs that treat type 2 diabetes do not have a significant effect on Alzheimer ...
It’s well known that AD has a strong genetic component. Apolipoprotein E (APOE4) is expressed in 40% to 65% of all AD ...
In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.
News-Medical.Net on MSN
New discovery could reshape how scientists think about Alzheimer’s treatment
Rutgers neuroscientist Peng Jiang was visiting his hometown of Qianshan, a city in China's Anhui province, when a neighbor ...
"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of ...
Congresswoman Maxine Waters (CA-43) joined more than 1,000 participants at the 2025 Walk to End Alzheimer’s – Los Angeles on ...
Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...
Scientists have found that a mutation tied to Alzheimer’s disrupts the production and quality of exosomes—tiny cell-made ...
A Korean research team has identified the most effective OLED color capable of enhancing cognitive function in Alzheimer's ...
"Now we have a lot of new studies coming in that are working on actually mild to moderate Alzheimer's Disease which is very ...
As more than 7 million Americans live with Alzheimer's, a North Texas family is urging caregivers to seek help early after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback